Everafenib is a highly selective BRAF inhibitor that effectively penetrates the blood-brain barrier (BBB) and inhibits MAPK signaling pathways. It demonstrates potent activity against various V600E BRAF melanoma cell lines, with IC50 values ranging from 2 to 10 nM, showcasing superior potency compared to other BRAF inhibitors. In vitro and in vivo studies indicate its efficacy in treating metastatic melanoma, including significant effects observed in an intracranial mouse model. This makes Everafenib a valuable tool for cancer research and therapeutic developments targeting BRAF mutations.
Everafenib is a highly selective BRAF inhibitor that effectively penetrates the blood-brain barrier (BBB) and inhibits MAPK signaling pathways. It demonstrates potent activity against various V600E BRAF melanoma cell lines, with IC50 values ranging from 2 to 10 nM, showcasing superior potency compared to other BRAF inhibitors. In vitro and in vivo studies indicate its efficacy in treating metastatic melanoma, including significant effects observed in an intracranial mouse model. This makes Everafenib a valuable tool for cancer research and therapeutic developments targeting BRAF mutations.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
